Cargando…
Infliximab/vedolizumab: Drug-induced lupus, pneumonitis and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256961/ http://dx.doi.org/10.1007/s40278-021-98375-1 |
Ejemplares similares
-
Infliximab: Lack of efficacy: case report
Publicado: (2021) -
Methylprednisolone/infliximab/anakinra: Lack of efficacy: case report
Publicado: (2021) -
Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis
por: Kaneoka, Ayaka, et al.
Publicado: (2022) -
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
por: Randhawa, Manreet, et al.
Publicado: (2019) -
Infliximab-Induced Interstitial Pneumonitis: A Case Report
por: Makkawy, Eyad A, et al.
Publicado: (2023)